Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kronox Lab SciencesNSE:KRONOX -3.67%43 Return-on-Tangible-Equity is 25.16% as of Jun. 2026, which is 33% below its 10-year median of 37.39. GuruFocus rates NSE:KRONOX with a GF Score™ of 43/100. The stock has 3 warning signs investors should review. Among 1,577 Chemicals companies, Kronox Lab Sciences ranks better than 92.96% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Kronox Lab Sciences's annualized net income for the quarter that ended in Jun. 2026 was ₹292 Mil. Kronox Lab Sciences's average shareholder tangible equity for the quarter that ended in Jun. 2026 was ₹1,161 Mil. Therefore, Kronox Lab Sciences's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2026 was 25.16%.
The historical rank and industry rank for Kronox Lab Sciences's Return-on-Tangible-Equity or its related term are showing as below:
NSE:KRONOX'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 26.82 Med: 37.39 Max: 40.58
Current: 27.86
During the past 6 years, Kronox Lab Sciences's highest Return-on-Tangible-Equity was 40.58%. The lowest was 26.82%. And the median was 37.39%.
NSE:KRONOX's Return-on-Tangible-Equity is ranked better than 92.96% of 1577
companies
in the Chemicals industry
Industry Median: 6.77
vs NSE:KRONOX: 27.86
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Kronox Lab Sciences Return-on-Tangible-Equity Related Terms
Kronox Lab Sciences Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Kronox Lab Sciences's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:KRONOX vs LIN, SHW, ECL: Return-on-Tangible-Equity Comparison
For the Specialty Chemicals subindustry, Kronox Lab Sciences's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kronox Lab Sciences Return-on-Tangible-Equity vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Kronox Lab Sciences's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Kronox Lab Sciences's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Jun. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 25.16% mean?
Kronox Lab Sciences (NSE:KRONOX) has a Return-on-Tangible-Equity of 25.16% as of Jun. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Kronox Lab Sciences and its competitors. This is 33% below median its historical median of 37.39. Over the past decade, Kronox Lab Sciences' Return-on-Tangible-Equity has ranged from 26.82 to 40.58. According to the industry distribution chart, Kronox Lab Sciences ranks #111 out of 1577 companies in the Chemicals industry, placing it in the top 7%.
Is Kronox Lab Sciences' Return-on-Tangible-Equity too high?
Kronox Lab Sciences' current Return-on-Tangible-Equity of 25.16% is 33% below median its 10-year median of 37.39. Over the past 10 years, this metric has ranged from a low of 26.82 to a high of 40.58. The Chemicals industry median Return-on-Tangible-Equity is 6.77. Kronox Lab Sciences' value of 25.16% is 271.6% above this industry median. Based on the distribution chart, Kronox Lab Sciences ranks #111 out of 1577 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Kronox Lab Sciences has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Kronox Lab Sciences' Return-on-Tangible-Equity compare to LIN and SHW?
According to the Chemicals industry distribution chart, Kronox Lab Sciences ranks #111 out of 1577 companies for Return-on-Tangible-Equity. This places Kronox Lab Sciences in the top 7% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 6.77. Kronox Lab Sciences' value of 25.16% is 271.6% above this benchmark. Historically, Kronox Lab Sciences' own Return-on-Tangible-Equity has ranged from 26.82 to 40.58 over the past decade. While the company's 10-year median is 37.39 vs. the industry median of 6.77, Kronox Lab Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Chemicals company?
The median Return-on-Tangible-Equity among Chemicals companies is 6.77, based on 1,577 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kronox Lab Sciences's current Return-on-Tangible-Equity of 25.16% is 271.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Kronox Lab Sciences and its competitors. For the Chemicals industry, the median Return-on-Tangible-Equity is 6.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kronox Lab Sciences's current Return-on-Tangible-Equity is 25.16%, which is 33% below median its own 10-year median of 37.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kronox Lab Sciences stock overvalued right now?
Kronox Lab Sciences (NSE:KRONOX) has a current Return-on-Tangible-Equity of 25.16%. The current Return-on-Tangible-Equity is 25.16%, which is 33% below median its 10-year median of 37.39 and 271.6% above the Chemicals industry median of 6.77. Kronox Lab Sciences' overall GF Score™ is 43/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Kronox Lab Sciences (NSE:KRONOX), the current Return-on-Tangible-Equity is 25.16% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kronox Lab Sciences Ltd manufactures High Purity Speciality Fine Chemicals for diversified end-user industries. The company's Fine inorganic Chemicals are used mainly as reacting agents and raw materials in the manufacturing of Active Pharmaceutical Ingredients; excipients in pharmaceutical formulations; reagents for scientific research and laboratory testing; ingredients in nutraceuticals formulations; process intermediates and fermenting agents in biotech applications; ingredients in agrochemical formulations; ingredients in personal care products; refining agents in metal refineries; and ingredients in animal health products, amongst others.
43GF Score
Get the complete analysis for NSE:KRONOX
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:KRONOX has been successfully added to your 
